These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31102655)

  • 81. Using the CRISPR-Cas System to Solve Porcine Viral Infection-related Issues.
    Liao F; Tang YD; Tan L; Yao J; Zheng C; Wang A
    CRISPR J; 2021 Dec; 4(6):776-788. PubMed ID: 34935492
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Unexplored power of CRISPR-Cas9 in neuroscience, a multi-OMICs review.
    Banazadeh M; Abiri A; Poortaheri MM; Asnaashari L; Langarizadeh MA; Forootanfar H
    Int J Biol Macromol; 2024 Apr; 263(Pt 2):130413. PubMed ID: 38408576
    [TBL] [Abstract][Full Text] [Related]  

  • 83. CRISPR-based pathogenic fungal genome editing for control of infection and disease.
    Arazoe T
    Prog Mol Biol Transl Sci; 2021; 179():161-196. PubMed ID: 33785176
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The prospects of CRISPR-based genome engineering in the treatment of neurodegenerative disorders.
    Shin JW; Lee JM
    Ther Adv Neurol Disord; 2018; 11():1756285617741837. PubMed ID: 29399048
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Genetic engineering: Allele-specific genome editing of disease loci.
    Waldron D
    Nat Rev Genet; 2016 Nov; 17(11):660. PubMed ID: 27694808
    [No Abstract]   [Full Text] [Related]  

  • 86. Online Databases of Genome Editing in Cardiovascular and Metabolic Diseases.
    Carrillo-Rodriguez P; Martinez-Lopez J; Gómez-Hernández L; Boraita-Morales L; Uceda-Molina M; Cuenca-Bermejo I; Valencia-Aguirre JP; Mora-López M; Plaza-Diaz J
    Adv Exp Med Biol; 2023; 1396():19-33. PubMed ID: 36454457
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Genome Editing Tools for Lysosomal Storage Disorders.
    Gonzalez EA; Nader H; Siebert M; Suarez DA; Alméciga-Díaz CJ; Baldo G
    Adv Exp Med Biol; 2023; 1429():127-155. PubMed ID: 37486520
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Traceable Nano-Biohybrid Complexes by One-Step Synthesis as CRISPR-Chem Vectors for Neurodegenerative Diseases Synergistic Treatment.
    Shen J; Lu Z; Wang J; Hao Q; Ji W; Wu Y; Peng H; Zhao R; Yang J; Li Y; Shi Z; Zhang X
    Adv Mater; 2021 Jul; 33(27):e2101993. PubMed ID: 34046943
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Engineering a compact genome-editing tool.
    Crunkhorn S
    Nat Rev Drug Discov; 2023 Dec; 22(12):953. PubMed ID: 37884601
    [No Abstract]   [Full Text] [Related]  

  • 90. The best Cas scenario.
    Smith PA
    Nat Med; 2018 May; 24(5):528-530. PubMed ID: 29736029
    [No Abstract]   [Full Text] [Related]  

  • 91. Unraveling of Central Nervous System Disease Mechanisms Using CRISPR Genome Manipulation.
    Vesikansa A
    J Cent Nerv Syst Dis; 2018; 10():1179573518787469. PubMed ID: 30013417
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Focus on CRISPR tools and therapies.
    Nat Biotechnol; 2020 Jul; 38(7):765. PubMed ID: 32641851
    [No Abstract]   [Full Text] [Related]  

  • 93. CRISPR/Cas9-mediated PINK1 deletion leads to neurodegeneration in rhesus monkeys.
    Yang W; Liu Y; Tu Z; Xiao C; Yan S; Ma X; Guo X; Chen X; Yin P; Yang Z; Yang S; Jiang T; Li S; Qin C; Li XJ
    Cell Res; 2019 Apr; 29(4):334-336. PubMed ID: 30770867
    [No Abstract]   [Full Text] [Related]  

  • 94. Gene-editing pipeline takes off.
    Mullard A
    Nat Rev Drug Discov; 2020 Jun; 19(6):367-372. PubMed ID: 32415249
    [No Abstract]   [Full Text] [Related]  

  • 95. A dual-specific CRISPR-Cas nanosystem for precision therapeutic editing of liver disorders.
    Xu X; Tang H; Guo J; Xin H; Ping Y
    Signal Transduct Target Ther; 2022 Aug; 7(1):269. PubMed ID: 35953473
    [No Abstract]   [Full Text] [Related]  

  • 96. Engineered virus-like particles: paving the way for effective somatic genome editing.
    Zhuo C; Tao Y; Li M
    Signal Transduct Target Ther; 2022 Aug; 7(1):279. PubMed ID: 35961953
    [No Abstract]   [Full Text] [Related]  

  • 97. Enhancing sheepgrass through genomic exploration and targeted editing.
    Sun M; Huang S; Zhou Y
    Sci China Life Sci; 2024 Mar; 67(3):629-630. PubMed ID: 38217638
    [No Abstract]   [Full Text] [Related]  

  • 98. Finding function with base editing screens.
    Koch L
    Nat Rev Genet; 2021 Apr; 22(4):200-201. PubMed ID: 33623155
    [No Abstract]   [Full Text] [Related]  

  • 99. Jennifer Doudna.
    Mullard A
    Nat Rev Drug Discov; 2020 Jun; 19(6):380-381. PubMed ID: 32415248
    [No Abstract]   [Full Text] [Related]  

  • 100. Accounting for diversity in the design of CRISPR-based therapeutic genome editing.
    Saha K
    Nat Genet; 2023 Jan; 55(1):6-7. PubMed ID: 36593304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.